| Trial ID: | L3927 |
| Source ID: | NCT01763346
|
| Associated Drug: |
Metformin
|
| Title: |
Beta Cell Restoration Through Fat Mitigation
|
| Acronym: |
BetaFat
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01763346/results
|
| Conditions: |
Prediabetes|Type 2 Diabetes|Obesity
|
| Interventions: |
DRUG: Metformin|DEVICE: gastric banding
|
| Outcome Measures: |
Primary: Steady State Beta Cell Compensation, mean plasma C-peptide concentration during clamp steady state, adjusted for mean clamp insulin sensitivity, 24 months | Other: Glycemia, fasting and 2-hour OGTT glucose levels, 24 months|Glycemia, HbA1C, 24 months
|
| Sponsor/Collaborators: |
Sponsor: University of Southern California | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
88
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2013-06
|
| Completion Date: |
2018-06
|
| Results First Posted: |
2019-10-21
|
| Last Update Posted: |
2019-10-21
|
| Locations: |
University of Southern California, Los Angeles, California, 91011, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01763346
|
